Comparing the quality of life of endometriotic patients’ before and after treatment with normal and infertile patients based on the EHP30 questionnaire

Table 6 Endometriosis-related pain and self-rate assessment in endometriotic patients without infertility via VAS score before and after treatment

Variable	Type of treatment	Medical group N = 50	Surgical group N = 50	P1	P2	P3
Noncyclic pain	Before	6.64 ± 2.49	7.41 ± 1.80	0 < .001	0 < .001	0.002
	After	3.32 ± 3.58	1.75 ± 2.68
	Difference	3.32 ± 3.03	5.66 ± 2.48
Dysmenorrhea	Before	7.72 ± 2.17	8.04 ± 2.16	0 < .001	0 < .001	0.003
	After	3.75 ± 2.77	1.97 ± 2.89
	Difference	3.97 ± 3.08	6.07 ± 3.09
Deep dyspareunia	Before	6.11 ± 2.58	6.64 ± 2.37	.008	0 < .001	0.001
	After	4.88 ± 2.96	2.14 ± 2.96
	Difference	1.22 ± 1.73	4.5 ± 1.93
GI symptom at menses	Before	5.81 ± 2.78	7.63 ± 2.05	0 < .001	0 < .001	0.051
	After	1.93 ± 2.93	1.27 ± 2.18
	Difference	3.87 ± 2.55	6.36 ± 2.46
Urinary symptom at menses	Before	5.833 ± 2.483	6.64 ± 2.23	0 < .001	0 < .001	0.1
	After	1.0 ± 2.44	0.286 ± .726
	Difference	4.83 ± 2.64	6.35 ± 2.097
Total	Before	6.42 ± 2.51	7.27 ± 2.27	0 < .001	0 < .001	0 < .001
	After	3.0 ± 2.93	1.48 ± 2.71
	Difference	3.42 ±2.62	5.79 ± 2.83

All the results are presented as the mean ± SD
P1: P-value refers to comparisons between month 0 and months 3 within the groups (Wilcoxon or paired t test as appropriate)
P2: P-value refers to comparisons between the groups at the end of the study (Kruskal-Wallis test or ANOVA as appropriated)
P3: P-value refers to comparison of the difference among the groups (Kruskal-Wallis test or ANOVA as appropriated)

ISSN: 1472-6874